Cremimycin
Cremimycin has anti-Gram-positive bacteria activity including methicillin-resistant Staphylococcus aureus (MRSA), MIC is 0.2-0.39 μg/mL. Cremimycin shows cytotoxicity to mouse tumor cell lines P388, L1210, IMC, S180, B16 and SS3 in vitro[1].
Product Specifications
CAS Number
[182285-29-6]
UNSPSC
12352211
Target
Bacterial
Related Pathways
Anti-infection
Field of Research
Cancer; Infection
Smiles
OC1=C2C(/C=C(/C=C/C=C/C(NC(CC(CCCC(CC2=O)O)=O)CCCCCC)=O)C)([H])CC1OC3CC(C(C(O3)C)O)OC
Molecular Formula
C35H53NO9
Molecular Weight
631.80
References & Citations
[1]M Igarashi, et al. Cremimycin, a novel 19-membered macrocyclic lactam antibiotic, from Streptomyces sp. J Antibiot (Tokyo) . 1998 Feb;51 (2) :123-9.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-N14144/
Scientific Category
Natural Products
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15098272 1 Vial
Lentiviral human EGFL6 shRNA (UAS) - Lentiviral human EGFL6 shRNA (UAS, iRFP) plasmid
Ask
View Details